Mérieux Equity Partners Announces Agreement to Sell Majority of its Stake in Swixx Biopharma.

Mérieux Equity Partners is pleased to announce that an agreement has been signed with SK Capital to sell the majority of its stake in Swixx Biopharma, a portfolio company of Mérieux Participations 4 (“MP4”).